Table 2 Supportive attitude towards a non-pharmaceutical intervention strategy to control COVID-19 among respondents by subgroups
Subgroup | Percentage of supportiveness | ARR (95%CI) | P of ARR | NNT (95%CI) |
|---|---|---|---|---|
Sex | ||||
Male vs. female | 91.8% vs. 93.8% | 2.0% (1.4–2.6%) | < 0.001 | 50 (38–71) |
Adjusted† | 91.8% vs. 93.8% | 2.0% (1.4–2.6%) | < 0.001 | 50 (38–71) |
Degree course | ||||
Undergraduate vs. postgraduate | 92.4% vs. 95.2% | 2.8% (2.1–3.5%) | < 0.001 | 35 (29–48) |
Adjusted† | 93.4% vs. 95.2% | 1.8% (0.5–3.0%) | 0.003 | 57 (33–200) |
Primary degree | ||||
Medicine vs. other | 93.2% vs. 92.5% | 0.6% (0.1–1.2%) | 0.029 | 157 (83–1000) |
Adjusted† | 92.7% vs. 92.5% | 0.2% (−0.4 to 0.8%) | 0.55 | 540 (− 250 to 125) |
Depression score | ||||
< 16 vs. ≥16 | 93.8% vs. 90.5% | 3.3% (2.6–3.9%) | < 0.001 | 30 (26–38) |
Adjusted† | 94.2% vs. 90.5% | 3.7% (3.0–4.4%) | 0.002 | 27 (23–33) |
Anxiety score | ||||
< 50 vs. ≥50 | 92.9% vs. 72.5% | 20.4% (14.2–26.6%) | < 0.001 | 5 (4–7) |
Adjusted† | 95.8% vs. 72.5% | 23.3% (16.6–30.0%) | < 0.001 | 4 (3–6) |
Exposure history | ||||
No vs. Yes | 92.9% vs. 91.5% | 1.4% (0.1–2.7%) | 0.026 | 73 (37–1000) |
Adjusted† | 95.8% vs. 91.5% | 4.3% (2.8–5.8%) | < 0.001 | 23 (17–36) |